ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Merck KGaA has agreed to sell its consumer health business, featuring brands such as Seven Seas vitamins and Oral-B toothpaste, and a number of over-the-counter (OTC) drugs, to Procter & Gamble for $4.2 billion. The business generated sales in 2017 of $1.1 billion across 44 countries; it has production sites in Spittal, Austria, and Goa, India. The divestment leaves the German company with three divisions: health care, life sciences, and performance materials. Merck intends to use money from the sale to reduce debt. The firm announced plans to sell the business in September 2017.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X